Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation
Abstract
Respiratory syncytial virus (RSV) pneumonia in marrow transplant recipients is associated with significant mortality. Ribavirin is a nucleoside analog with activity against RSV and in its aerosolized formulation is the only drug approved for treatment of RSV pneumonia in the United States. The clini …
Keywords
injections
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
adult
female
male
middle aged
P.H.S.
Clinical Trial
antiviral agents / administration & dosage
antiviral agents / therapeutic use*
ribavirin / administration & dosage
ribavirin / therapeutic use*
respiratory syncytial virus infections / drug therapy*
respiratory syncytial virus infections / virology
pmid:8913463
pmc163574
doi:10.1128/aac.40.11.2555
phase i
d m lewinsohn
r a bowden
s w crawford
bone marrow transplantation / physiology*
intravenous
postoperative complications / drug therapy*
postoperative complications / virology
Access
Citation
ID:
112689
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112689
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet